
Visp
Vista Alpina
Augenzentrum
Bahnhofplatz 1a
3930 Visp
T. 027 946 70 00
F. 027 946 70 03
Sprechstunde
Montag - Freitag:
08.00 - 12.00 Uhr
13.00 - 19.30 Uhr
(Dienstags, Mittwochs und Freitags bis 18:00 Uhr)
Samstag:
08.00 - 12.00 Uhr
Termine nach
tel. Vereinbarung
Siders
Vista Alpina
Augenzentrum
Rue du Bourg 3
3960 Sierre
T. 027 455 34 04
F. 027 455 34 77
Sprechstunde
Montag, Mittwoch, Freitag:
08.00 - 12.00 Uhr
12.30 - 18.00 Uhr
(Montag 12.45 Uhr)
Dienstag:
07.00 - 12.00 Uhr
12.45 - 19.00 Uhr
Donnerstag:
08.00 - 12.00 Uhr
12.45 - 17.30 Uhr
Samstag: geschlossen
Termine nach
tel. Vereinbarung

Ausbildung und Werdegang
2018 -
Senior Advisor, Partners Group (Zug, Switzerland)
2008 -
Founder, medical director, chief surgeon Vista Alpina eye center, Visp/Sierre, Switzerland
2005 - 2012
Training in ophthalmology and ophthalmic surgery: Lucerne cantonal eye clinic (PD I. Schipper), Inselspital Berne eye clinic (Prof. S. Wolf), Dr. Agarwal eye hospital (Chenai, India), Vista Alpina eye clinic (Switzerland)
2001 - 2005
Global Marketing Manager, and Global Medical Manager, Cardiovascular franchise, Novartis International, Basel, Switzerland and Tokyo, Japan
1999 - 2001
Medical advisor, Cardiovascular, Pfizer, Belgium
1998 - 2000
Master of Business Administration (executive MBA, Vlerick Leuven-Ghent Management School, Belgium
1997 - 1999
Head of clinical studies, Therabel Pharma, Belgium
1997 - 1998
Master in pharmaceutical medicine, University of Brussels, Belgium
1996 - 1997
Cardiology, University Hospital "Jolimont”, La Louvière, Belgium
1989 - 1996
Medical School, University of Gent, Belgium
Disclaimer:
Augenzentrum Vista Alpina AG und die von dem Augenzentrum Vista Alpina erbrachten Leistungen stehen in keiner rechtlichen oder tatsächlichen Verbindung zur Vista Klinik AG, Laser Vista AG, Vista Klinik Net AG oder Vista Diagnostics AG.
Mitgliedschaften
Walliser Ärzteverband (WÄV)
Verbindung der Schweizer Ärtinnen und Ärzte (FMH)
Schweizerische Ophthalmologische Gesellschaft (SOG)
European Society of Cataract and Refractive Surgeons (ECRS)
American Academy of Ophthalmology (AAO)
SAC Zermatt
Auszeichnungen
2014
Best of the Best Presentation at the ESCRS (European Society of Cataract and Refractive Surgery) September 17, 2014, London, UK.
K. Vandekerckhove.
Ankoris: a new toric IOL with insufficient rotational stability after cataract surgery
1995
Posterpreis am Symposium der Belgian Association of Clinical Biology (Erstautor): „De immuunstatus voor rubella en toxoplasma bij meisjes tussen 12 en 18 jaar“
1989
Gewinner der flämischen Chemie-Olympiade und Teilnahme an der internationalen Chemie-Olympiade in Halle, ehemalige DDR
Kongressveröffentlichungen
2014
Swiss Society of Ophthalmology, Annual Meeting, August 27-30, 2014, Interlaken, Switzerland.
K. Vandekerckhove.
Aflibercept versus Ranibizumab in diabetic macular edema.
2014
Swiss Society of Ophthalmology, Annual Meeting, August 27-30, 2014, Interlaken, Switzerland.
K. Vandekerckhove.
Aflibercept in eyes with incomplete response to Ranibizumab in AMD.
2014
EURETINA, 14th International Congress, September 11 – 14, 2014, London, UK.
K. Vandekerckhove.
Aflibercept versus ranibizumab in diabetic macular edema.
2013
ESASO European School for Advanced Studies in Opthalmology, 13th International AMD and Retina Congress, October 25 – 26, 2013, Dublin, Ireland.
K. Vandekerckhove.
Aflibercept Therapy For Exudative Age-Related Macular Degeneration In Eyes With Incomplete Reponse To Ranibizumab.
2012
Swiss Society of Ophthalmology, Annual Meeting, August 29 - September 1, 2012, Fribourg, Switzerland.
K. Vandekerckhove.
Ranibizumab und Retinopathia centralis serosa (RCS).
2008
ARVO The Association for Research in Vision and Ophthalmology, 2008.
Barbara Kloeckener-Gruissem, Gudrun Nürnberg, John Neidhardt, Christina Zeitz, Stephan Labs, Daniel Schorderet, Francis Munier, Anthony Moore, Shomi Bhattacharya, Kristof Vandekerckhove, Peter Nürnberg, and Wolfgang Berger.
Genetic mapping and identification of a stop mutation in a monocarboxylate transporter: association with juvenile cataract, microcornea and renal glucosuria.
2006
Swiss Society of Ophthalmology, Annual Meeting, September 6-9, 2006, Lugano, Switzerland.
K. Vandekerckhove and O. Job.
NAION (Non-Arteritic Anterior Ischemic Optic Neuropathy) after a long airplane-flight in a young adult.
2006
Swiss Society of Ophthalmology, Annual Meeting, September 6-9, 2006, Lugano, Switzerland.
K. Vandekerckhove, A.Lange and I. Schipper.
Juvenile cataract associated with micro-cornea and isolated glucosuria: a new syndrome.
2001
14th Cardiology Update, February 12-16, 2001, Davos, Switzerland.
K Vandekerckhove, O Gurné, P Block, G Berkenboom, JM Boeynaems.
BIMED, Biological Markers of Endothelial Dysfunction.
2001
14th Cardiology Update, February 12-16, 2001, Davos, Switzerland.
P Block, JL Rouleau, W van Gilst, Ch Bauters, W Warnica, K Vandekerckhove
IMAGINE, Ischemic Management with Accupril post bypass Graft via Inhibition of converting Enzyme.
1997
International Symposium on nitric oxide, basic and clinical pharmacology, Odense, Denmark, June 9-10, 1997.
R.A. Lefebvre and K. Vandekerckhove.
Influence of NO donors and long-term electrical stimulation on nitrergic relaxations in the pig gastric fundus.
1997
44th Annual Meeting of the Society of Nuclear Medicine, San Antonio, Texas, Jun 1-5, 1997.
C. De Sadeleer, M. Simons, C. Van de Wiele, H. Thierens, K. Vandekerckhove, and R.A. Dierckx.
Technetium-99m HDP scintigraphic follow-up of patients treated for primary malignant bone tumor by bone autograft after external high-dose radiation therapy.
1995
Symposium of the Belgian Association of Clinical Biology, Luik, October 14th 1995.
Vandekerckhove K., Verstraete A., Leroux-Roels G.
De immuunstatus voor rubella en toxoplasma bij meisjes tussen 12 en 18 jaar.
Publikationen
2018
Vandekerckhove K., Rotational Stability of Monofocal and Trifocal Intraocular Toric Lenses With Identical Design and Material but Different Surface Treatment, J Refract Surg. 2018;34(2):84-91
2015
Vandekerckhove K., Aflibercept versus ranibizumab for treating persistent diabetic macular oedema, International Ophthalmology 2015; 35(4):603-9
2009
Lange AP, Vandekerckhove K., Becht C, Zakrzewski PA, Schmid MK.
Spontaneous closure of a traumatic macular hole.
Klin Monatsbl Augenheilkd. 2009 Apr ; 226(4):359-60
2008
B. Kloeckener-Gruissem*, K. Vandekerckhove* et al (* first authors, equal contribution)
Mutation of the solute carrier SLC16A12 associates with a novel syndrome combining autosomal dominant juvenile cataract with microcornea and glucosuria.
American Journal of Human Genetic 2008
2007
Vandekerckhove K., Lange A. P., Herzog D. C. J., Schipper I.
Juvenile cataract associated with micro-cornea and glucosuria: a new syndrome. Klin Monatsbl Augenh 2007; 224:344-346
1998
R.A. Lefebvre and K. Vandekerckhove.
Influence of nitroglycerine and long-term electrical stimulation on nitrergic relaxations in the pig gastric fundus, British Journal of Pharmacology, 123, 143-149, (1998).
1998
Ginsberg F., Joos E., Géczy J., Bruhwyler J., Vandekerckhove K. and Famaey JP.
A pilot randomized placebo-controlled study of pirlindole in the treatment of primary fibromyalgia, Journal of Musculoskeletal Pain, 6(2), 5-17, (1998).
1998
Famaey J.P., Vandekerckhove K., Géczy J. and Bruhwyler J.
A large open-label trial of nimesulide in patients with osteoarticular conditions treated in a general practice setting, Current therapeutic Research, 59(7), 467-482, (1998).
1998
Famaey J.P., Bruhwyler J., Géczy J., Vandekerckhove K. and Appelboom T.
Open controlled randomized multicenter comparison of nimesulide and diclofenac in the treatment of subacute and chronic low back pain, Journal of Clinical Research, 1, 219-238, (1998).
1997
Bruhwyler J., Monseu M-J., Vandekerckhove K. and Géczy J.
Pirlindole, a reversible and specific monoamine oxidase A inhibitor: A retrospective evaluation of its clinical antidepressant profile,
European Journal of Clinical Research, 9, 225-245, (1997).
1997
Braeckman J., Bruhwyler J., Vandekerckhove K. & Géczy J.
Efficacy and safety of the extract of Serenoa repens in the treatment of benign prostatic hyperplasia: therapeutic equivalence between twice and once daily dosage forms, Phytotherapy Research, Vol. 11, 558-563, (1997).
1996
Vandekerckhove K. , Verstraete A., Leroux-Roels G.
Immunity against toxoplasma and rubella in girls between 12 and 18 years old.
Acta Clin. Belg., 1996 (abstract).
1996
Vandekerckhove K., Verstraete A., Leroux-Roels G.
De immuunstatus voor rubella en toxoplasma bij meisjes tussen 12 en 18 jaar.
Tijdschr. Geneesk., 1996; 52 : 319-323
Vorträge
Über 100 Vorträge an Kongressen im In- und Ausland, für (Augen-) Ärzte, für Optiker, für Apotheker und für Patienten.